Table of Contents
ISRN Surgery
Volume 2014, Article ID 385386, 3 pages
Research Article

Pathology Slide Review in Vulvar Cancer Does Not Change Patient Management

1Department of Gynecological Oncology, Erasmus Medical Center, Rotterdam, Cancer Institute, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands
2Department of Radiation Therapy, Erasmus Medical Center, Cancer Institute, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands
3Department of Pathology, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands

Received 15 October 2013; Accepted 11 November 2013; Published 25 March 2014

Academic Editors: M. G. Chiofalo and G. I. Salti

Copyright © 2014 Maaike Beugeling et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Hypothesis. Pathology slide review in vulvar cancer is only necessary in a restricted number of cases. Methods. A retrospective chart review of all cases of vulvar cancer treated in a tertiary centre between January 1, 2000, and April 1, 2006. Histopathology reports from the referring and tertiary centre were compared. Results. 121 pathology reports from 112 patients were reviewed. Of the original reports, 56% were deemed adequate, commenting on tumor type and depth of infiltration; of the reviews, 83% were adequate. Conclusion. There were no discrepancies that influenced patient management. We suggest that vulvar cancer biopsies need to be reviewed only when the tumor is less than 10 mm in linear extension, when the infiltration is 1 mm or less, when there is no residual tumor on inspection, and in any nonsquamous cancer.